EP3174901
OPTIMIZED CROSS-SPECIES SPECIFIC BISPECIFIC SINGLE CHAIN ANTIBODY CONSTRUCTS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
31.7.2015EP published:
26.6.2019EP application number:
15756479.0
EPO information:
European Patent Register
Max expiry date:
30.7.2035
Title:
OPTIMIZED CROSS-SPECIES SPECIFIC BISPECIFIC SINGLE CHAIN ANTIBODY CONSTRUCTS
Timeline
Today
31.7.2015EP application
26.6.2019EP Publication
Owner
Name:
Amgen Research (Munich) GmbHAddress:
Staffelseestrasse 2, 81477, München, DE
Inventor
Name:
RATTEL, BennoAddress:
Munich, DE
Name:
FRIEDRICH, MatthiasAddress:
Munich, DE
Name:
KUFER, PeterAddress:
Munich, DE
Name:
HOFFMANN, PatrickAddress:
Munich, DE
Name:
RAUM, TobiasAddress:
Munich, DE
Name:
MUNZ, MarkusAddress:
Munich, DE
Name:
HERRMANN, InesAddress:
Munich, DE
Name:
LUTTERBUESE, RalfAddress:
Munich, DE
Name:
NAHRWOLD, ElisabethAddress:
Munich, DE
Priority
Number:
201462031784 PDate:
31.7.2014Country:
US
Classification
Categories:
C07K 16/18, C07K 16/28, C07K 16/46